SG Americas Securities LLC Boosts Stake in Cardinal Health, Inc. $CAH

SG Americas Securities LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH) by 57.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,147,406 shares of the company’s stock after acquiring an additional 419,895 shares during the period. SG Americas Securities LLC’s holdings in Cardinal Health were worth $242,458,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank purchased a new stake in Cardinal Health in the fourth quarter worth $790,344,000. Wellington Management Group LLP raised its holdings in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Holocene Advisors LP lifted its position in Cardinal Health by 141.4% during the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock valued at $302,332,000 after buying an additional 1,128,358 shares during the period. Marshall Wace LLP lifted its position in Cardinal Health by 1,328.1% during the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after buying an additional 884,648 shares during the period. Finally, Barclays PLC boosted its holdings in shares of Cardinal Health by 109.3% during the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after buying an additional 827,446 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $222.08 on Monday. The business has a fifty day moving average price of $204.34 and a 200-day moving average price of $209.28. The company has a market capitalization of $52.01 billion, a PE ratio of 33.96, a PEG ratio of 1.21 and a beta of 0.52. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the previous year, the business posted $2.35 EPS. Cardinal Health’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is presently 31.19%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CAH shares. Evercore reduced their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Barclays lifted their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Citigroup lowered their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 15th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.